动态增强MRI乳腺背景实质强化的临床应用进展
Clinical Application Progress of Dynamic Contrast-Enhanced MRI in Breast Background Parenchymal Enhancement
李思叶 1黄子康 2沈君 3徐滨 4于越洋 2朱玉春5
作者信息
- 1. 南京医科大学 姑苏学院,江苏 苏州 215002;昆山市第一人民医院放射科,江苏 苏州 215300
- 2. 江苏大学 医学院,江苏 镇江 212013
- 3. 昆山市第二人民医院 超声科,江苏 苏州 215300
- 4. 昆山市第一人民医院放射科,江苏 苏州 215300
- 5. 南京医科大学 姑苏学院,江苏 苏州 215002;昆山市第一人民医院核医学科,江苏 苏州 215300
- 折叠
摘要
乳腺癌在女性恶性肿瘤中发病率较高,且呈逐年上升的趋势.乳腺动态增强MRI中的背景实质强化(Background Parenchymal Enhancement,BPE)可作为促进乳腺病变定向精准诊断和治疗可持续发展的影像生物学标志物.BPE指乳腺正常纤维腺体的强化受多种因素影响,包括乳腺血供情况和机体内外源激素等.本文综述了BPE的分类及定量测量、BPE的影响因素、BPE与乳腺癌发病风险的相关性、BPE与乳腺癌新辅助化疗及预后的关系.
Abstract
Breast cancer has a high incidence rate among female malignant tumors,and the this rate is showing an increasing trend year by year.Background parenchymal enhancement(BPE)in breast dynamic contrast-enhanced MRI can be used as an image biomarker for promoting the targeted,precise diagnosis and treatment of breast lesions for sustainable development.BPE refers to the enhancement of normal fibroglandular breast tissue,influenced by various factors including breast blood supply,endogenous and exogenous hormones.This paper reviewed the classification and quantitative measurement of BPE,factors influencing BPE,the correlation between BPE and the risk of breast cancer,as well as the relationship between BPE,neoadjuvant chemotherapy for breast cancer,and prognosis.
关键词
背景实质强化/乳腺癌/乳腺动态增强磁共振/乳腺癌分子亚型/新辅助化疗Key words
background parenchymal enhancement/breast cancer/breast dynamic contrast-enhanced MRI/molecular subtypes of breast cancer/neoadjuvant chemotherapy引用本文复制引用
出版年
2024
国家科技期刊平台
NSTL
万方数据